Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

ALT – Altimmune Inc

Name : Altimmune, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $0.0000
EPSttm :
finviz dynamic chart for ALT
[iframe https://s.tradingview.com/embed-widget/symbol-info/?locale=in&symbol=ALT #%7B%22symbol%22%3A%22A%22%2C%22width%22%3A%22100%25%22%2C%22colorTheme%22%3A%22light%22%2C%22isTransparent%22%3Atrue%2C%22height%22%3A203%2C%22utm_source%22%3A%22themarketstracker.com%22%2C%22utm_medium%22%3A%22widget_new%22%2C%22utm_campaign%22%3A%22symbol-info%22%7D 900 250 ]
[iframe https://api.stockdio.com/visualization/financial/charts/v1/PricesChange?app-key=F086EEE750E14D8D8A456DB88B2D6D8C&symbol=ALT &conditionalVolume=false&allowPeriodChange=false&tooltipsStyle=None&palette=Financial-Light&showBorderAndTitle=false 300 200 ]

Float Short %

30.4

Margin Of Safety %

Put/Call OI Ratio

0.41

EPS Next Q Diff

-0.07

EPS Last/This Y

0.07

EPS This/Next Y

-0.29

Price

3.87

Target Price

22.38

Analyst Recom

1.22

Performance Q

-27.26

Relative Volume

4.13

Beta

0.47

Ticker: ALT




20 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-06-02ALT5.290.320.30210332
2025-06-03ALT5.410.320.25218493
2025-06-04ALT5.490.320.33223018
2025-06-05ALT5.490.320.33233583
2025-06-06ALT5.610.320.55238202
2025-06-09ALT5.950.340.73235281
2025-06-10ALT6.730.340.40240141
2025-06-11ALT6.530.360.59252075
2025-06-12ALT7.150.370.34259530
2025-06-13ALT6.910.370.83264848
2025-06-16ALT6.870.381.66254953
2025-06-17ALT6.870.450.53275700
2025-06-18ALT6.780.450.58287350
2025-06-20ALT7.020.460.59295441
2025-06-23ALT70.471.52208843
2025-06-24ALT7.190.540.85231800
2025-06-25ALT7.720.570.91251046
2025-06-26ALT3.630.590.56266482
2025-06-27ALT3.490.491.47287360
2025-06-30ALT3.870.410.26225319
DateSymbolLastP/C OIP/C VolTotal OI
20 items Current Page1 of 1




20 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-06-02ALT5.2915.8-33.6-1.24
2025-06-03ALT5.4215.8-43.3-1.24
2025-06-04ALT5.4915.8-49.7-1.24
2025-06-05ALT5.4615.8-46.2-1.24
2025-06-06ALT5.6115.8-52.8-1.27
2025-06-09ALT5.9514.1-31.6-1.27
2025-06-10ALT6.7414.1-43.5-1.27
2025-06-11ALT6.5314.1-17.1-1.27
2025-06-12ALT7.1514.1-36.6-1.27
2025-06-13ALT6.9114.1-16.8-1.27
2025-06-16ALT6.8714.1-20.9-1.27
2025-06-17ALT6.8714.1-23.0-1.27
2025-06-18ALT6.7814.1-19.4-1.27
2025-06-20ALT7.0314.1-27.5-1.27
2025-06-23ALT7.0014.1-21.4-1.27
2025-06-24ALT7.1814.1-26.0-1.27
2025-06-25ALT7.7214.1-33.2-1.27
2025-06-26ALT3.6014.157.0-1.27
2025-06-27ALT3.4914.1-14.0-1.27
2025-06-30ALT3.8714.1-46.4-1.27
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
20 items Current Page1 of 1




20 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-06-02ALT1.32-5.8628.25
2025-06-03ALT1.32-5.8628.25
2025-06-04ALT1.32-5.8628.25
2025-06-05ALT1.32-5.8628.25
2025-06-06ALT1.32-5.8628.25
2025-06-09ALT1.32-5.7628.25
2025-06-10ALT1.32-5.7628.25
2025-06-11ALT1.32-5.7627.39
2025-06-12ALT1.32-5.7627.39
2025-06-13ALT1.32-5.7627.39
2025-06-16ALT1.32-5.6527.39
2025-06-17ALT1.32-5.6527.39
2025-06-18ALT1.32-5.6527.39
2025-06-19ALT1.32-5.6527.39
2025-06-20ALT1.32-5.6527.39
2025-06-24ALT1.32-5.6527.39
2025-06-25ALT1.32-5.6527.39
2025-06-26ALT1.32-5.6530.40
2025-06-27ALT1.32-5.6530.40
2025-06-30ALT1.32-5.6530.40
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
20 items Current Page1 of 1

[iframe https://widget.finnhub.io/widgets/historical-eps?symbol=ALT 589 360 ]

Last Quarter Act. EPS

-0.26

Avg. EPS Est. Current Quarter

-0.3

Avg. EPS Est. Next Quarter

-0.33

Insider Transactions

1.32

Institutional Transactions

-5.65

Beta

0.47

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

26

Growth Score

33

Sentiment Score

1

Actual DrawDown %

89

Max Drawdown 5-Year %

-93.6

Target Price

22.38

P/E

Forward P/E

PEG

P/S

15693.96

P/B

2.12

P/Free Cash Flow

EPS

-1.25

Average EPS Est. Cur. Y​

-1.27

EPS Next Y. (Est.)

-1.56

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-451200

Relative Volume

4.13

Return on Equity vs Sector %

-87.3

Return on Equity vs Industry %

-68.2

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.02

EBIT Estimation

-46.4
[iframe https://widget.finnhub.io/widgets/recommendation?symbol=ALT 589 450 ]
[iframe https://widget.finnhub.io/widgets/eps-estimate?symbol=ALT 589 450 ]
Altimmune, Inc.
Sector: Healthcare
Industry: Biotechnology
Employees: 59
Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity, metabolic, and liver diseases. Its lead product candidate is pemvidutide, a GLP-1/glucagon dual receptor agonist, which is in Phase 3 trial for the treatment of obesity and metabolic associated steatohepatitis. The company was founded in 1997 and is headquartered in Gaithersburg, Maryland.
stock quote shares ALT – Altimmune Inc Stock Price stock today
news today ALT – Altimmune Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch ALT – Altimmune Inc yahoo finance google finance
stock history ALT – Altimmune Inc invest stock market
stock prices ALT premarket after hours
ticker ALT fair value insiders trading

ALT – Altimmune, Inc.

Altimmune, Inc.
ALT
$3.87
Name : Altimmune, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $313,884,096.00
EPSttm : -1.26
finviz dynamic chart for ALT
Altimmune, Inc.
$3.87
10.57%
$0.37

Float Short %

30.4

Margin Of Safety %

Put/Call OI Ratio

0.41

EPS Next Q Diff

-0.07

EPS Last/This Y

0.07

EPS This/Next Y

-0.29

Price

3.87

Target Price

22.38

Analyst Recom

1.22

Performance Q

-27.26

Relative Volume

4.13

Beta

0.47

Ticker: ALT




20 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-06-02ALT5.290.320.30210332
2025-06-03ALT5.410.320.25218493
2025-06-04ALT5.490.320.33223018
2025-06-05ALT5.490.320.33233583
2025-06-06ALT5.610.320.55238202
2025-06-09ALT5.950.340.73235281
2025-06-10ALT6.730.340.40240141
2025-06-11ALT6.530.360.59252075
2025-06-12ALT7.150.370.34259530
2025-06-13ALT6.910.370.83264848
2025-06-16ALT6.870.381.66254953
2025-06-17ALT6.870.450.53275700
2025-06-18ALT6.780.450.58287350
2025-06-20ALT7.020.460.59295441
2025-06-23ALT70.471.52208843
2025-06-24ALT7.190.540.85231800
2025-06-25ALT7.720.570.91251046
2025-06-26ALT3.630.590.56266482
2025-06-27ALT3.490.491.47287360
2025-06-30ALT3.870.410.26225319
DateSymbolLastP/C OIP/C VolTotal OI
20 items Current Page1 of 1




20 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-06-02ALT5.2915.8-33.6-1.24
2025-06-03ALT5.4215.8-43.3-1.24
2025-06-04ALT5.4915.8-49.7-1.24
2025-06-05ALT5.4615.8-46.2-1.24
2025-06-06ALT5.6115.8-52.8-1.27
2025-06-09ALT5.9514.1-31.6-1.27
2025-06-10ALT6.7414.1-43.5-1.27
2025-06-11ALT6.5314.1-17.1-1.27
2025-06-12ALT7.1514.1-36.6-1.27
2025-06-13ALT6.9114.1-16.8-1.27
2025-06-16ALT6.8714.1-20.9-1.27
2025-06-17ALT6.8714.1-23.0-1.27
2025-06-18ALT6.7814.1-19.4-1.27
2025-06-20ALT7.0314.1-27.5-1.27
2025-06-23ALT7.0014.1-21.4-1.27
2025-06-24ALT7.1814.1-26.0-1.27
2025-06-25ALT7.7214.1-33.2-1.27
2025-06-26ALT3.6014.157.0-1.27
2025-06-27ALT3.4914.1-14.0-1.27
2025-06-30ALT3.8714.1-46.4-1.27
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
20 items Current Page1 of 1




20 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-06-02ALT1.32-5.8628.25
2025-06-03ALT1.32-5.8628.25
2025-06-04ALT1.32-5.8628.25
2025-06-05ALT1.32-5.8628.25
2025-06-06ALT1.32-5.8628.25
2025-06-09ALT1.32-5.7628.25
2025-06-10ALT1.32-5.7628.25
2025-06-11ALT1.32-5.7627.39
2025-06-12ALT1.32-5.7627.39
2025-06-13ALT1.32-5.7627.39
2025-06-16ALT1.32-5.6527.39
2025-06-17ALT1.32-5.6527.39
2025-06-18ALT1.32-5.6527.39
2025-06-19ALT1.32-5.6527.39
2025-06-20ALT1.32-5.6527.39
2025-06-24ALT1.32-5.6527.39
2025-06-25ALT1.32-5.6527.39
2025-06-26ALT1.32-5.6530.40
2025-06-27ALT1.32-5.6530.40
2025-06-30ALT1.32-5.6530.40
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
20 items Current Page1 of 1

Last Quarter Act. EPS

-0.26

Avg. EPS Est. Current Quarter

-0.3

Avg. EPS Est. Next Quarter

-0.33

Insider Transactions

1.32

Institutional Transactions

-5.65

Beta

0.47

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

26

Growth Score

33

Sentiment Score

1

Actual DrawDown %

89

Max Drawdown 5-Year %

-93.6

Target Price

22.38

P/E

Forward P/E

PEG

P/S

15693.96

P/B

2.12

P/Free Cash Flow

EPS

-1.25

Average EPS Est. Cur. Y​

-1.27

EPS Next Y. (Est.)

-1.56

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-451200

Relative Volume

4.13

Return on Equity vs Sector %

-87.3

Return on Equity vs Industry %

-68.2

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.02

EBIT Estimation

-46.4
Altimmune, Inc.
Sector: Healthcare
Industry: Biotechnology
Employees: 59
Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity, metabolic, and liver diseases. Its lead product candidate is pemvidutide, a GLP-1/glucagon dual receptor agonist, which is in Phase 3 trial for the treatment of obesity and metabolic associated steatohepatitis. The company was founded in 1997 and is headquartered in Gaithersburg, Maryland.
stock quote shares ALT – Altimmune, Inc. Stock Price stock today
news today ALT – Altimmune, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch ALT – Altimmune, Inc. yahoo finance google finance
stock history ALT – Altimmune, Inc. invest stock market
stock prices ALT premarket after hours
ticker ALT fair value insiders trading